ArticleFrontiers in endocrinology2026
Association of LH rising before luteal support and reproductive outcomes in artificial frozen embryo transfer cycles.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: In natural cycles, rising estradiol (E2) suppresses pituitary luteinizing hormone (LH) secretion until a threshold is reached, triggering the LH surge and ovulation. During artificial-cycle frozen embryo transfer (AC-FET), prolonged E2 exposure may induce endogenous LH elevation before progesterone administration. Limited studies have examined the impact of LH dynamics on reproductive outcomes in AC-FET cycles. This study investigated the association between LH rising before luteal support and reproductive outcomes and further explored the relative contributions of basal LH, and pre-P LH. Methods: This retrospective cohort study included patients aged 25-44 years undergoing D3 or D5 AC-FET without GnRH agonist suppression. A total of 582 cycles were categorized according to the LH rising ratio, defined as pre-progesterone LH divided by basal LH. Cycles were classified as LH rising ratio <3 (group 1) or ≥3 (group 2). Outcomes included implantation (IR), clinical pregnancy (CPR), ongoing pregnancy (OPR), and abortion rates (AR). Results: In D3 embryo transfer cycles, an LH rising ratio ≥3 was associated with lower IR (21.1% vs. 13.2%; OR 0.57, 95% CI 0.38-0.82) and CPR (43.3% vs. 28.4%; OR 0.52, 95% CI 0.31-0.87). AR was higher and OPR lower, although not statistically significant. Similar trends were observed in D5 cycles without statistical significance. After adjustment using multivariable generalized estimating equation models, the associations in D3 cycles remained significant. However, decoupling analyses suggested that the LH rising ratio primarily functioned as a surrogate marker of lower basal LH rather than an independent effect of elevated pre-P LH, as basal LH remained associated with implantation outcomes whereas pre-P LH did not. Quartile analyses did not demonstrate a threshold effect for either basal LH or pre-P LH. Conclusion: A higher LH rising ratio before progesterone supplementation was associated with reduced implantation and clinical pregnancy rates in D3 AC-FET cycles. Additional analyses suggest that the LH rising ratio may primarily serve as a surrogate marker of lower basal LH rather than an independent effect of elevated pre-P LH. The relationship between LH dynamics and reproductive outcomes remains complex and may not be fully explained by basal or pre-P LH alone.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.